Causal Association Between Female Infertility and Circulating Immune Cells: A Bidirectional Mendelian Randomization
Xuan Zhou1, Yu-Xuan Fang1, Li-Ya Ma1
1Henan University of Chinese Medicine, Zhengzhou, China.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|February 25, 2025
Summary
This study used Mendelian randomization to find a causal link between specific immune cells and female infertility (FI). These findings offer new insights into FI
Area of Science:
- Immunology
- Genetics
- Reproductive Medicine
Background:
- Female infertility (FI) is a significant global health concern with incompletely understood causes.
- Immunologic factors are increasingly recognized as playing a crucial role in the etiology of FI.
Purpose of the Study:
- To investigate the potential causal association between various immune cells and the risk of developing female infertility.
- To leverage Mendelian randomization (MR) analysis for elucidating genetic links between immunophenotypes and FI.
Main Methods:
- Employed a two-sample Mendelian randomization (MR) approach using genetic variants as instrumental variables.
- Analyzed the causal correlation between 731 peripheral blood lymphocyte immunophenotypes and FI.
- Utilized weighted median estimator (WME) and inverse variance weighted (IVW) methods, alongside sensitivity analyses to ensure data reliability and minimize bias.
Main Results:
- Identified four immune cell phenotypes significantly associated with FI risk.
- Specific associations include CD33dim HLA DR+CD11b+ (OR: 0.98), CD39+CD4+AC (OR: 1.03), CD27 on IgD-CD38bright (OR: 0.93), and CD28 on resting Treg (OR: 0.91).
- Sensitivity analyses confirmed the robustness and reliability of these findings.
Conclusions:
- Provided evidence for a causal relationship between specific immune cells and female infertility.
- Contributes novel literature to the understanding of FI pathogenesis.
- Establishes a foundation for exploring immunomodulatory therapeutic strategies for FI.
Related Concept Videos
Infertility in Males
228
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
228
Infertility in Females
256
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
256
Oogenesis
63.3K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.3K
Nondisjunction
3.7K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
3.7K


